Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000757359 | SCV000885552 | pathogenic | not provided | 2017-12-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000757359 | SCV002588280 | pathogenic | not provided | 2022-03-25 | criteria provided, single submitter | clinical testing | Identified in a 6 month old male with hemolytic anemia and cyanosis in published literature (Park et al., 2012); Published functional studies suggest a damaging effect resulting in lower oxygen affinity and increased 2,3-DPG concentration (May et al., 1975); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as Hb Hammersmith; This variant is associated with the following publications: (PMID: 1911375, 19429541, 24471820, 1201210, 29084024, 22217314) |
OMIM | RCV000016371 | SCV000036639 | other | HEMOGLOBIN HAMMERSMITH | 1988-06-01 | no assertion criteria provided | literature only | |
OMIM | RCV000016372 | SCV000036640 | other | HEMOGLOBIN CHIBA | 1988-06-01 | no assertion criteria provided | literature only | |
OMIM | RCV000016373 | SCV000036641 | pathogenic | Heinz body anemia | 1988-06-01 | no assertion criteria provided | literature only | |
Natera, |
RCV001831570 | SCV002089224 | pathogenic | beta Thalassemia | 2017-03-17 | no assertion criteria provided | clinical testing |